OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates
Sajad Fakhri, Zeinab Nouri, Seyed Zachariah Moradi, et al.
Molecules (2021) Vol. 26, Iss. 10, pp. 2917-2917
Open Access | Times Cited: 16
Sajad Fakhri, Zeinab Nouri, Seyed Zachariah Moradi, et al.
Molecules (2021) Vol. 26, Iss. 10, pp. 2917-2917
Open Access | Times Cited: 16
Showing 16 citing articles:
Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome
Takumi Satoh, Dorit Trudler, Chang-ki Oh, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 124-124
Open Access | Times Cited: 92
Takumi Satoh, Dorit Trudler, Chang-ki Oh, et al.
Antioxidants (2022) Vol. 11, Iss. 1, pp. 124-124
Open Access | Times Cited: 92
In silico evaluation of food‐derived carotenoids against SARS‐CoV ‐2 drug targets: Crocin is a promising dietary supplement candidate for COVID ‐19
Somdutt Mujwar, Lei Sun, Özkan Fidan
Journal of Food Biochemistry (2022) Vol. 46, Iss. 9
Open Access | Times Cited: 37
Somdutt Mujwar, Lei Sun, Özkan Fidan
Journal of Food Biochemistry (2022) Vol. 46, Iss. 9
Open Access | Times Cited: 37
In silico discovery of multi-targeting inhibitors for the COVID-19 treatment by molecular docking, molecular dynamics simulation studies, and ADMET predictions
Aso Hameed Hasan, Narmin Hamaamin Hussen, Sonam Shakya, et al.
Structural Chemistry (2022) Vol. 33, Iss. 5, pp. 1645-1665
Closed Access | Times Cited: 29
Aso Hameed Hasan, Narmin Hamaamin Hussen, Sonam Shakya, et al.
Structural Chemistry (2022) Vol. 33, Iss. 5, pp. 1645-1665
Closed Access | Times Cited: 29
Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
Sajad Fakhri, Seyed Zachariah Moradi, Akram Yarmohammadi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 28
Sajad Fakhri, Seyed Zachariah Moradi, Akram Yarmohammadi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 28
Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review
Sajad Fakhri, Seyed Zachariah Moradi, Angela Ash-Rafzadeh, et al.
Pharmacological Research (2021) Vol. 177, pp. 105961-105961
Closed Access | Times Cited: 29
Sajad Fakhri, Seyed Zachariah Moradi, Angela Ash-Rafzadeh, et al.
Pharmacological Research (2021) Vol. 177, pp. 105961-105961
Closed Access | Times Cited: 29
Ameliorating COVID-19-related Acute respiratory distress syndrome (ARDS) with the multi-target strategy utilising natural supplements-from in-silico to a randomised controlled clinical trial
A.R. Amjadi, Masoomeh Mohammadpour, Khadijeh Pouraghajan, et al.
International Journal of Ayurvedic Medicine (2025) Vol. 15, Iss. 4, pp. 935-945
Open Access
A.R. Amjadi, Masoomeh Mohammadpour, Khadijeh Pouraghajan, et al.
International Journal of Ayurvedic Medicine (2025) Vol. 15, Iss. 4, pp. 935-945
Open Access
An allosteric mechanism for potent inhibition of SARS-CoV-2 main proteinase
Yunju Zhang, Jingjing Guo, Yang Liu, et al.
International Journal of Biological Macromolecules (2024) Vol. 265, pp. 130644-130644
Closed Access | Times Cited: 3
Yunju Zhang, Jingjing Guo, Yang Liu, et al.
International Journal of Biological Macromolecules (2024) Vol. 265, pp. 130644-130644
Closed Access | Times Cited: 3
Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs
Suvasmita Rath, Venkateswarlu Perikala, Atala Bihari Jena, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112095-112095
Open Access | Times Cited: 21
Suvasmita Rath, Venkateswarlu Perikala, Atala Bihari Jena, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112095-112095
Open Access | Times Cited: 21
Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance
Sajad Fakhri, Seyed Zachariah Moradi, Farahnaz Faraji, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 959-1020
Closed Access | Times Cited: 8
Sajad Fakhri, Seyed Zachariah Moradi, Farahnaz Faraji, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 959-1020
Closed Access | Times Cited: 8
Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm
Paulina Niedźwiedzka‐Rystwej, Adam Majchrzak, Sara Kurkowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4545-4545
Open Access | Times Cited: 13
Paulina Niedźwiedzka‐Rystwej, Adam Majchrzak, Sara Kurkowska, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4545-4545
Open Access | Times Cited: 13
Quercetin Derivatives in Combating Spinal Cord Injury: A Mechanistic and Systematic Review
Sajad Fakhri, Mohammad Mehdi Gravandi, Sadaf Abdian, et al.
Life (2022) Vol. 12, Iss. 12, pp. 1960-1960
Open Access | Times Cited: 13
Sajad Fakhri, Mohammad Mehdi Gravandi, Sadaf Abdian, et al.
Life (2022) Vol. 12, Iss. 12, pp. 1960-1960
Open Access | Times Cited: 13
NSAIDs and Kelleni’s protocol as potential early COVID-19 treatment game changer: could it be the final countdown?
Mina Kelleni
Inflammopharmacology (2021) Vol. 30, Iss. 1, pp. 343-348
Open Access | Times Cited: 16
Mina Kelleni
Inflammopharmacology (2021) Vol. 30, Iss. 1, pp. 343-348
Open Access | Times Cited: 16
Transplacental Transmission of SARS-CoV-2: A Narrative Review
Minh Tien Bui, Cam Anh Nguyen Le, Khanh Linh Duong, et al.
Medicina (2024) Vol. 60, Iss. 9, pp. 1517-1517
Open Access | Times Cited: 2
Minh Tien Bui, Cam Anh Nguyen Le, Khanh Linh Duong, et al.
Medicina (2024) Vol. 60, Iss. 9, pp. 1517-1517
Open Access | Times Cited: 2
Marine Compounds, Mitochondria, and Malignancy: A Therapeutic Nexus
Sajad Fakhri, Sadaf Abdian, Seyed Zachariah Moradi, et al.
Marine Drugs (2022) Vol. 20, Iss. 10, pp. 625-625
Open Access | Times Cited: 9
Sajad Fakhri, Sadaf Abdian, Seyed Zachariah Moradi, et al.
Marine Drugs (2022) Vol. 20, Iss. 10, pp. 625-625
Open Access | Times Cited: 9
Suppressive effect of isofraxidin on the overexpression of IL-6 and its molecular mechanism
Taisuke Yamazaki, Takayoshi Tokiwa
Research Square (Research Square) (2024)
Open Access
Taisuke Yamazaki, Takayoshi Tokiwa
Research Square (Research Square) (2024)
Open Access
Suppressive effect of isofraxidin on the overexpression of IL-6 and its molecular mechanism in a TPA-treated human hepatocellular carcinoma cell line, HuH-7
Taisuke Yamazaki, Takayoshi Tokiwa
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Taisuke Yamazaki, Takayoshi Tokiwa
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
